NDRI: Publications

You are currently filtering by: 2014 Cancer lung

Cancer • 2014 • Oncotarget 5(14): 5674–5685. PMID: 26473505.

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.

Hall AB, Newsome D, Wang Y, Boucher DM, Eustace B, Gu Y, Hare B, Johnson MA, Milton S, Murphy CE, Takemoto D, Tolman C, Wood M, Charlton P, Charrier JD, Furey B, Golec J, Reaper PM, Pollard JR

Full Article

Cancer • 2014 • Virchows Archiv 464(4): 495-503. PMID: 24570392.

In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.

Gao L, Yue MM, Davis J, Hyjek E, Schuger L

Full Article

NDRI is a Not-For-Profit (501c3) Corporation.

Publications

You are currently filtering by: 2014 Cancer lung

National Disease Research Interchange